2013 Emerging Entrepreneur: Amit Bhattacharya, PhD
Amit Bhattacharya, PhD, is doing something about the staggering price of health care in the United States: He played a key role in developing a tool that could make a serious dent in the $20 billion in annual direct costs associated with osteoporosis, a disease that thins and weakens the bones to the point that they become fragile and break easily.
Bhattacharya, a professor in the department of environmental healths division of environmental and occupational hygiene, teamed with Nelson Watts, MD, a UC College of Medicine faculty member until January 2012, to develop a technology called Bone Shock Absorbance (BSA), which uses small devices called accelerometers attached to the patients body to measure how energy from a heel strike is absorbed and dissipated through the musculoskeletal system.
This painless, non-invasive 10-minute test represents an advance over the current "gold standard of predicting osteoporosis by using bone mineral density measured with X-ray technology, which is done while the patient is at rest and leads to inappropriate or insufficient treatments.
Bhattacharya is the recipient of the 2013 Emerging Entrepreneur Achievement Award. He was honored at the All-University Faculty Awards celebration April 17, 2013.
Bhattacharya and Watts licensed the technology from UC and formed the company OsteoDynamics, Inc., with the goal of commercializing it. Toward that end, the company has secured over $550,000 in financial support through grants and equity investments.
In November 2012, Bhattacharya was awarded a $40,000 grant through the UC Provosts Pilot Research Program, one of four programs of the College of Medicines $1 million Discovery Acceleration Initiative. This award will help test technical and scientific enhancements of the technology.
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.